Angioplasty

Peripheral Guidewires - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Interventional radiology, Health care, Clinical medicine, Angioplasty, Percutaneous, Stent, Catheter, Balloon catheter, Angiography, Cordis

Peripheral Guidewires - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Peripheral Guidewires within the Cardiovascular Devices market.

Key Points: 
  • Peripheral Guidewires - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Peripheral Guidewires within the Cardiovascular Devices market.
  • Peripheral Guidewires are used during percutaneous transluminal angioplasty (PTA) for guiding stents or balloon catheters to the site of blockage in the peripheral vasculature.
  • The Peripheral Guidewires Market is segmented into Hydrophilic Peripheral Guidewires and Non-Hydrophilic Peripheral Guidewires.
  • - Annualized total Peripheral Guidewires market revenue by segment and market outlooks from 2005-2024.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Clinical medicine, Percutaneous coronary intervention, PTCA, Angioplasty, Interventional cardiology, Percutaneous, Johnson & Johnson, Balloon catheter, Cordis, Drug-eluting stent

Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters within the Cardiovascular Devices market.

Key Points: 
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters within the Cardiovascular Devices market.
  • - Currently marketed Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters and evolving competitive landscape.
  • - Annualized total Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters market revenue by segment and market outlooks from 2005-2024.
  • - Develop business strategies by understanding the trends shaping and driving the Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters market.

Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Clinical medicine, Interventional radiology, Angioplasty, Percutaneous, Balloon catheter, Catheter, PTA, Cordis, Percutaneous coronary intervention

Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters within the Cardiovascular Devices market.

Key Points: 
  • Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters within the Cardiovascular Devices market.
  • - Annualized total Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters market revenue by segment and market outlooks from 2005-2024.
  • - Develop business strategies by understanding the trends shaping and driving the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters market.
  • - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters market in the future.

Peripheral Guidewires - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Interventional radiology, Health care, Clinical medicine, Angioplasty, Percutaneous, Stent, Catheter, Balloon catheter, Angiography, Cordis

Peripheral Guidewires - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Peripheral Guidewires within the Cardiovascular Devices market.

Key Points: 
  • Peripheral Guidewires - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Peripheral Guidewires within the Cardiovascular Devices market.
  • Peripheral Guidewires are used during percutaneous transluminal angioplasty (PTA) for guiding stents or balloon catheters to the site of blockage in the peripheral vasculature.
  • The Peripheral Guidewires Market is segmented into Hydrophilic Peripheral Guidewires and Non-Hydrophilic Peripheral Guidewires.
  • - Annualized total Peripheral Guidewires market revenue by segment and market outlooks from 2005-2024.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Clinical medicine, Percutaneous coronary intervention, PTCA, Angioplasty, Interventional cardiology, Percutaneous, Johnson & Johnson, Balloon catheter, Cordis, Drug-eluting stent

Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters within the Cardiovascular Devices market.

Key Points: 
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters within the Cardiovascular Devices market.
  • - Currently marketed Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters and evolving competitive landscape.
  • - Annualized total Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters market revenue by segment and market outlooks from 2005-2024.
  • - Develop business strategies by understanding the trends shaping and driving the Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon Catheters market.

Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Clinical medicine, Interventional radiology, Angioplasty, Percutaneous, Balloon catheter, Catheter, PTA, Cordis, Percutaneous coronary intervention

Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters within the Cardiovascular Devices market.

Key Points: 
  • Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters within the Cardiovascular Devices market.
  • - Annualized total Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters market revenue by segment and market outlooks from 2005-2024.
  • - Develop business strategies by understanding the trends shaping and driving the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters market.
  • - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters market in the future.

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance

Retrieved on: 
Tuesday, May 22, 2018
Medicine, Clinical medicine, Angioplasty, Interventional radiology, CAAS, Angiography, Cardiology, Health care

Based on this, cardiologist may take a decision on whether a coronary stenosis has to be treated with angioplasty or not.

Key Points: 
  • Based on this, cardiologist may take a decision on whether a coronary stenosis has to be treated with angioplasty or not.
  • CAAS vFFR allows clinicians to use two standard angiograms taken during a standard catheterization procedure as input to get access to coronary physiology assessment.
  • FAST, a clinical study led by Ken Masdjedi, MD and Joost Daemen MD, PhD from Erasmus Medical Center, Rotterdam shows that vFFR as calculated using CAAS vFFR has a high linear correlation to invasively measured FFR.
  • CAAS vFFR received USA 510(k) market clearance and is CE marked and PMDA cleared (Japan).

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance

Retrieved on: 
Tuesday, May 22, 2018
Medicine, Clinical medicine, Angioplasty, Interventional radiology, CAAS, Angiography, Cardiology, Health care

Based on this, cardiologist may take a decision on whether a coronary stenosis has to be treated with angioplasty or not.

Key Points: 
  • Based on this, cardiologist may take a decision on whether a coronary stenosis has to be treated with angioplasty or not.
  • CAAS vFFR allows clinicians to use two standard angiograms taken during a standard catheterization procedure as input to get access to coronary physiology assessment.
  • FAST, a clinical study led by Ken Masdjedi, MD and Joost Daemen MD, PhD from Erasmus Medical Center, Rotterdam shows that vFFR as calculated using CAAS vFFR has a high linear correlation to invasively measured FFR.
  • CAAS vFFR received USA 510(k) market clearance and is CE marked and PMDA cleared (Japan).

Tasigna Lawsuit News: Recent Studies Suggest Leukemia Drug May Increase Risk for Arteriosclerosis, Peripheral Artery Disease and Related Vascular Conditions, Bernstein Liebhard LLP Reports

Retrieved on: 
Thursday, May 17, 2018
Angiology, RTT, Circulatory system, Medicine, Interventional radiology, Angioplasty, Peripheral artery disease, Arteriosclerosis, Leukemia, Artery disease

All three required angioplasty and none had a prior history of peripheral artery disease before they began taking Tasigna.

Key Points: 
  • All three required angioplasty and none had a prior history of peripheral artery disease before they began taking Tasigna.
  • In 2013, researchers writing in the journal Leukemia reported that patients taking Tasigna were more likely to experience peripheral artery disease compared to those taking another CML drug called Gleevac.
  • "Our Firm has heard from numerous patients who were diagnosed with arteriosclerosis, peripheral artery disease, or related conditions after they began taking Tasigna to treat CML.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street,New York, New York10016, 800-511-5092.

FLEX Scoring Catheter Presented at 2018 Charing Cross International Symposium

Retrieved on: 
Monday, May 7, 2018
Medicine, Interventional radiology, Clinical medicine, Health care, Angioplasty, Catheter, Vascular surgery

The FLEX Scoring Catheter creates continuous longitudinal micro-incisions at a controlled depth that prepares the vessel for angioplasty.

Key Points: 
  • The FLEX Scoring Catheter creates continuous longitudinal micro-incisions at a controlled depth that prepares the vessel for angioplasty.
  • Dr. Frank Arko, Director, Endovascular Surgery, Co-Director of Aortic Institute at Carolinas Medical Center, Sanger Heart and Vascular Institute Charlotte, North Carolina, USA highlighted successes with the FLEX Scoring Catheter during the Innovations session "FLEX Scoring Catheter Vessel Preparation Device."
  • The presentation focused on an overview of the FLEX Scoring Catheter specifications, mechanism of action, cases, and techniques using this innovative advanced device for vessel preparation.
  • The FLEX Scoring Catheter data will be presented highlighting efficacy in long lesions.